Mizoribine requires individual dosing due to variation of bioavailability

  • Individual dosing for mizoribine
  • Toshiya Fuke, Yoshifusa Abe, Satoshi Hibino, Mikawa Takeshi, Takako Saito, Shunsuke Sakurai, Shuichiro Watanabe, Jun-Ichiro Murayama, Kazuo Itabashi, Yasuko Nakano
  • Pediatrics International, December 2012, Wiley
  • DOI: 10.1111/j.1442-200x.2012.03733.x

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1111/j.1442-200x.2012.03733.x

The following have contributed to this page: Professor Kazuo Itabashi